Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DE94CW
|
|||
| Drug Name |
AVXS-201
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Rett syndrome [ICD-11: LD90.4; ICD-10: F84.2] | Phase 1 | [1] | |
| Company |
Novartis
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Methyl cpg binding protein 2 (MECP2) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Novartis | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.